TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from Jinxin Fertility Group Ltd. ( (HK:1951) ).
Jinxin Fertility Group Ltd. has issued a profit warning, anticipating a loss of up to RMB1,090 million for the first half of 2025, primarily due to impairments and provisions related to its operations in the United States and Laos. Despite these challenges, the company remains confident in its long-term growth prospects, citing strong industry foundations and supportive national policies. Additionally, the company has appointed Mr. Dong Yang as the acting chief financial officer, who will oversee financial management and business development.
The most recent analyst rating on (HK:1951) stock is a Buy with a HK$3.33 price target. To see the full list of analyst forecasts on Jinxin Fertility Group Ltd. stock, see the HK:1951 Stock Forecast page.
More about Jinxin Fertility Group Ltd.
Jinxin Fertility Group Ltd. operates in the fertility industry, providing reproductive medical services. The company focuses on enhancing clinical treatment results, patient care, and service offerings, supported by favorable national policies and a solid industry foundation.
Average Trading Volume: 78,900,795
Technical Sentiment Signal: Buy
Current Market Cap: HK$8.84B
For an in-depth examination of 1951 stock, go to TipRanks’ Overview page.